Blackstone to Sell Wexford’s Life Science and Medical Assets
07.11.16
This is only gets display when printing
Simpson Thacher is representing Blackstone in connection with its sale of substantially all of the life science and medical real estate assets of Wexford Science & Technology LLC to Ventas Inc. (NYSE: VTR) for $1.5 billion. The sale will consist of 23 operating properties and two development assets, which Blackstone acquired with its purchase of BioMed Realty Trust in January. The transaction is subject to customary conditions and is expected to close in the fourth quarter of 2016.
The Simpson Thacher team includes Sas Mehrara, Krista Miniutti, Davis Coen, Whitney Salinas, Jason Mohr, Jacob Vadeboncoeur, Elliot Schwab, Rachel Stein and Ari Goldman (Real Estate); Greg Grogan and Andrew Blau (ECEB); and Nancy Mehlman and Jacqueline Clinton (Tax). Summer Associates Stephanie Brenner and Brendan Galloway provided valuable assistance.